Laboratoire Francais du Fractionnement et des Biotechnologies
发明人:
Guillaume CHEVREUX
申请号：
US16868803
公开号：
US20200270596A1
申请日:
2020.05.07
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a factor VII composition having a substantially homogeneous isoelectric point and to a method for formulating such a composition. The present invention also relates to the therapeutic use of a factor VII composition having a substantially homogeneous isoelectric point.
